메뉴 건너뛰기




Volumn 86, Issue 6, 2015, Pages 615-621

The natural history of early versus late disability accumulation in primary progressive MS

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ARTICLE; CONTROLLED STUDY; DISABILITY; DISEASE COURSE; EXPANDED DISABILITY STATUS SCALE; FEMALE; GENDER; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MOTOR DYSFUNCTION; MULTIPLE SCLEROSIS; ONSET AGE; PATIENT IDENTIFICATION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; AGED; COHORT ANALYSIS; LONGITUDINAL STUDY; MIDDLE AGED; MOVEMENT (PHYSIOLOGY); PATHOPHYSIOLOGY; RISK FACTOR; SENSATION; SEXUAL DEVELOPMENT; SURVIVAL;

EID: 84929995794     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2014-307948     Document Type: Article
Times cited : (16)

References (20)
  • 2
    • 34548633861 scopus 로고    scopus 로고
    • Primary-progressive multiple sclerosis
    • Miller DH, Leary SM. Primary-progressive multiple sclerosis. Lancet Neurol 2007;6:903-12.
    • (2007) Lancet Neurol , vol.6 , pp. 903-912
    • Miller, D.H.1    Leary, S.M.2
  • 3
    • 0021035886 scopus 로고
    • Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
    • Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444-52.
    • (1983) Neurology , vol.33 , pp. 1444-1452
    • Kurtzke, J.F.1
  • 4
    • 0034676548 scopus 로고    scopus 로고
    • Relapses and progression of disability in multiple sclerosis
    • Confavreux C, Vukusic S, Moreau T, et al. Relapses and progression of disability in multiple sclerosis. N Engl J Med 2000;343:1430-8.
    • (2000) N Engl J Med , vol.343 , pp. 1430-1438
    • Confavreux, C.1    Vukusic, S.2    Moreau, T.3
  • 5
    • 73349133703 scopus 로고    scopus 로고
    • The natural history of primary progressive multiple sclerosis
    • Koch M, Kingwell E, Rieckmann P, et al. The natural history of primary progressive multiple sclerosis. Neurology 2009;73:1996-2002.
    • (2009) Neurology , vol.73 , pp. 1996-2002
    • Koch, M.1    Kingwell, E.2    Rieckmann, P.3
  • 6
    • 0037379402 scopus 로고    scopus 로고
    • Early clinical predictors and progression of irreversible disability in multiple sclerosis: An amnesic process
    • Confavreux C, Vukusic S, Adeleine P. Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process. Brain J Neurol 2003;126:770-82.
    • (2003) Brain J Neurol , vol.126 , pp. 770-782
    • Confavreux, C.1    Vukusic, S.2    Adeleine, P.3
  • 7
    • 77954382272 scopus 로고    scopus 로고
    • Evidence for a two-stage disability progression in multiple sclerosis
    • Leray E, Yaouanq J, Le Page E, et al. Evidence for a two-stage disability progression in multiple sclerosis. Brain J Neurol 2010;133:1900-13.
    • (2010) Brain J Neurol , vol.133 , pp. 1900-1913
    • Leray, E.1    Yaouanq, J.2    Le Page, E.3
  • 8
    • 0020686503 scopus 로고
    • New diagnostic criteria for multiple sclerosis: Guidelines for research protocols
    • Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-31.
    • (1983) Ann Neurol , vol.13 , pp. 227-231
    • Poser, C.M.1    Paty, D.W.2    Scheinberg, L.3
  • 9
    • 79952501096 scopus 로고    scopus 로고
    • Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
    • Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria. Ann Neurol 2011;69:292-302.
    • (2011) Ann Neurol , vol.69 , pp. 292-302
    • Polman, C.H.1    Reingold, S.C.2    Banwell, B.3
  • 10
    • 0029913882 scopus 로고    scopus 로고
    • Defining the clinical course of multiple sclerosis: Results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis
    • Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 1996;46:907-11.
    • (1996) Neurology , vol.46 , pp. 907-911
    • Lublin, F.D.1    Reingold, S.C.2
  • 12
    • 0032946328 scopus 로고    scopus 로고
    • The natural history of multiple sclerosis: A geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosis
    • Cottrell DA, Kremenchutzky M, Rice GP, et al. The natural history of multiple sclerosis: a geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosis. Brain J Neurol 1999;122(Pt 4):625-39.
    • (1999) Brain J Neurol , vol.122 , pp. 625-639
    • Cottrell, D.A.1    Kremenchutzky, M.2    Rice, G.P.3
  • 13
    • 33846833929 scopus 로고    scopus 로고
    • Glatiramer acetate in primary progressive multiple sclerosis: Results of a multinational, multicenter, double-blind, placebo-controlled trial
    • Wolinsky JS, Narayana PA, O'Connor P, et al. Glatiramer acetate in primary progressive multiple sclerosis: results of a multinational, multicenter, double-blind, placebo-controlled trial. Ann Neurol 2007;61:14-24.
    • (2007) Ann Neurol , vol.61 , pp. 14-24
    • Wolinsky, J.S.1    Narayana, P.A.2    O'Connor, P.3
  • 14
    • 84883742744 scopus 로고    scopus 로고
    • Treatment trials in progressive MS-current challenges and future directions
    • Koch MW, Cutter G, Stys PK, et al. Treatment trials in progressive MS-current challenges and future directions. Nat Rev Neurol 2013;9:496-503.
    • (2013) Nat Rev Neurol , vol.9 , pp. 496-503
    • Koch, M.W.1    Cutter, G.2    Stys, P.K.3
  • 15
    • 84905819646 scopus 로고    scopus 로고
    • Defining the clinical course of multiple sclerosis: The 2013 revisions
    • Lublin FD, Reingold SC, Cohen JA, et al. Defining the clinical course of multiple sclerosis: the 2013 revisions. Neurology 2014;83:278-86.
    • (2014) Neurology , vol.83 , pp. 278-286
    • Lublin, F.D.1    Reingold, S.C.2    Cohen, J.A.3
  • 16
    • 0032881051 scopus 로고    scopus 로고
    • The natural history of multiple sclerosis: A geographically based study. 7. Progressive-relapsing and relapsing-progressive multiple sclerosis: A re-evaluation
    • Kremenchutzky M, Cottrell D, Rice G, et al. The natural history of multiple sclerosis: a geographically based study. 7. Progressive-relapsing and relapsing-progressive multiple sclerosis: a re-evaluation. Brain J Neurol 1999;122(Pt 10):1941-50.
    • (1999) Brain J Neurol , vol.122 , pp. 1941-1950
    • Kremenchutzky, M.1    Cottrell, D.2    Rice, G.3
  • 17
    • 33244486947 scopus 로고    scopus 로고
    • The natural history of multiple sclerosis: A geographically based study 9: Observations on the progressive phase of the disease
    • Kremenchutzky M, Rice GPA, Baskerville J, et al. The natural history of multiple sclerosis: a geographically based study 9: observations on the progressive phase of the disease. Brain J Neurol 2006;129:584-94.
    • (2006) Brain J Neurol , vol.129 , pp. 584-594
    • Kremenchutzky, M.1    Rice, G.P.A.2    Baskerville, J.3
  • 18
    • 0037029424 scopus 로고    scopus 로고
    • Multiple sclerosis
    • Compston A, Coles A. Multiple sclerosis. Lancet 2002;359:1221-31.
    • (2002) Lancet , vol.359 , pp. 1221-1231
    • Compston, A.1    Coles, A.2
  • 19
    • 33244469927 scopus 로고    scopus 로고
    • Age at disability milestones in multiple sclerosis
    • Confavreux C, Vukusic S. Age at disability milestones in multiple sclerosis. Brain J Neurol 2006;129:595-605.
    • (2006) Brain J Neurol , vol.129 , pp. 595-605
    • Confavreux, C.1    Vukusic, S.2
  • 20
    • 33244466021 scopus 로고    scopus 로고
    • Natural history of multiple sclerosis: A unifying concept
    • Confavreux C, Vukusic S. Natural history of multiple sclerosis: a unifying concept. Brain J Neurol 2006;129:606-16.
    • (2006) Brain J Neurol , vol.129 , pp. 606-616
    • Confavreux, C.1    Vukusic, S.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.